Autosomal Dominant Polycystic Kidney Disease

Detailed Overview

ADPKD is a systemic ciliopathy. Mutations in the PKD1 or PKD2 genes disrupt the function of polycystin-1 and polycystin-2, proteins located on the primary cilia of renal tubular epithelial cells. This defect causes abnormal intracellular calcium signaling and elevated cAMP, driving tubular cell proliferation and massive fluid secretion. Kidneys can eventually weigh over 5 kilograms each. Extra-renal manifestations are common and critical to survival, particularly the development of intracranial berry aneurysms and hepatic cysts.

Epidemiology & Demographics

Affects 1 in 400 to 1 in 1000 live births. Accounts for roughly 5-10% of all End-Stage Renal Disease cases worldwide. Occurs equally in men and women of all ethnicities.

Etiological Mechanism

Autosomal dominant inheritance. About 85% of cases are caused by mutations in the PKD1 gene (chromosome 16), which presents earlier and is more severe. 15% are caused by PKD2 mutations (chromosome 4), which presents later.

Primary Causes

Inherited genetic defect in polycystin proteins. Following a 'two-hit' somatic mutation model in individual tubular cells, cells lose differentiation, multiply, and secrete massive amounts of fluid, ballooning into cysts that detach from the nephron.

• Family History: An affected parent gives a child a 50% chance of inheriting the disease.
• PKD1 Genotype: Patients with PKD1 mutations reach ESRD roughly 15 years earlier than those with PKD2 mutations.
• Early Hypertension: Onset of high blood pressure before age 35 predicts rapid progression of cyst growth.

Defective polycystins on the primary cilia fail to sense mechanical flow, leading to a drop in intracellular Ca2+. This triggers adenylyl cyclase, raising intracellular cAMP. High cAMP activates PKA and the MAPK pathway, stimulating abnormal cell proliferation (cyst lining expansion) and upregulating CFTR channels (pumping chloride and water into the cyst). As cysts expand, they compress surrounding normal nephrons, causing localized ischemia. The kidneys respond by massive renin release, causing severe systemic hypertension, which further damages the surviving glomeruli.

Characteristic Clinical Presentation

• Flank Pain: Chronic dull ache from renal capsule stretch, or sharp acute pain from cyst hemorrhage or rupture.
• Hematuria: Episodes of gross, visible blood in the urine following cyst rupture.
• Early Satiety / Dyspnea: Massively enlarged kidneys compress the stomach and diaphragm.

Physical Examination Signs

• Palpable, massive bilateral flank masses on abdominal exam.
• Severe, difficult-to-control hypertension in a young adult (e.g., age 30).
• Mitral Valve Prolapse murmurs (mid-systolic click).

• Ruptured Berry Aneurysm: Occurs in ~10% of patients; subarachnoid hemorrhage is a major cause of extra-renal mortality.
• Cyst Infection: Lipid-soluble antibiotics (like ciprofloxacin) are required to penetrate the cyst wall.
• Nephrolithiasis: High risk of uric acid and calcium oxalate kidney stones.

Diagnostic Criteria & Guidelines

Pei-Ravine Ultrasound Criteria based on age and family history. For individuals with a family history: At age 15-39, the presence of ≥3 unilateral or bilateral renal cysts is diagnostic. At age 40-59, ≥2 cysts in each kidney is required. Genetic testing is reserved for ambiguous cases or living-related donor screening.

Differential Diagnosis

• Autosomal Recessive Polycystic Kidney Disease (ARPKD) - presents in infancy with severe liver fibrosis.
• Multiple Simple Cysts - common with aging, usually <5 cysts total, not massively enlarging the kidney.
• Acquired Cystic Kidney Disease - occurs in patients already on long-term dialysis.

Laboratory Tests & Biomarkers

• Serum Creatinine / eGFR: Remains normal for decades while cysts grow, then plummets rapidly in later life.
• Urinalysis: Microalbuminuria and mild hematuria. Lack of significant proteinuria differentiates it from glomerulonephritis.

Imaging Modalities & Findings

• Renal Ultrasound:
• Total Kidney Volume (TKV) by MRI:
• MRA Brain:

• Stage 1 (Normal GFR)
  Cysts are forming and growing. GFR is strictly maintained via hyperfiltration, but hypertension is common.
• Stage 3 CKD
  Significant renomegaly with GFR falling to 30-59 mL/min. Recurrent flank pain and UTI.
• Stage 5 CKD (ESRD)
  GFR < 15 mL/min. Requires dialysis or renal transplant. Usually occurs by age 55 in PKD1.

Second-Line & Adjunctive Therapy

Tolvaptan (a Vasopressin V2 receptor antagonist) for patients with rapid disease progression (rapidly increasing TKV or dropping GFR). Dose titrated from 45/15 mg to 90/30 mg daily. It dramatically reduces cAMP in cysts, slowing growth by 50%. It causes profound polyuria (up to 7L/day) and requires strict monthly monitoring for severe hepatotoxicity.

Surgical & Procedural Management

Renal replacement therapy (Dialysis or Kidney Transplantation) for ESRD. Native nephrectomy is strictly avoided unless the native kidneys are causing intractable pain, recurrent infected cysts, or are so massive there is no physical room for the transplant graft.

Recommended Lifestyle Changes

• Drink over 3-4 liters of water daily to naturally suppress vasopressin.
• Strict low-sodium diet (< 2 grams/day) to assist in blood pressure control.
• Avoid contact sports (football, martial arts) due to severe risk of cyst rupture and catastrophic bleeding.

Patient Counseling & Advice

Offer genetic counseling. Emphasize that hypertension is the silent driver of kidney destruction; they must take their ACE inhibitors even if they feel fine.

Follow-Up & Monitoring Schedule

Annual MRIs to calculate height-adjusted Total Kidney Volume (htTKV) using the Mayo classification system. Biannual GFR and electrolyte checks.

Preventive Strategies

No primary prevention exists. Preimplantation genetic diagnosis (PGD) with IVF is an option for affected parents wishing to ensure their offspring are unaffected.

ESRD is virtually inevitable, occurring at an average age of 54 for PKD1 and 74 for PKD2. Post-transplant prognosis is excellent, as the cysts do not recur in the grafted normal kidney.